Abstract
Pacritinib Demonstrates Efficacy Versus Best Available Therapy in Myelofibrosis Patients with Severe Thrombocytopenia in Two Phase 3 Studies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have